Literature DB >> 27780774

The contribution of the programmed cell death machinery in innate immune cells to lupus nephritis.

FuNien Tsai1, Harris Perlman2, Carla M Cuda3.   

Abstract

Systemic lupus erythematosus (SLE) is a chronic multi-factorial autoimmune disease initiated by genetic and environmental factors, which in combination trigger disease onset in susceptible individuals. Damage to the kidney as a consequence of lupus nephritis (LN) is one of the most prevalent and severe outcomes, as LN affects up to 60% of SLE patients and accounts for much of SLE-associated morbidity and mortality. As remarkable strides have been made in unlocking new inflammatory mechanisms associated with signaling molecules of programmed cell death pathways, this review explores the available evidence implicating the action of these pathways specifically within dendritic cells and macrophages in the control of kidney disease. Although advancements into the underlying mechanisms responsible for inducing cell death inflammatory pathways have been made, there still exist areas of unmet need. By understanding the molecular mechanisms by which dendritic cells and macrophages contribute to LN pathogenesis, we can improve their viability as potential therapeutic targets to promote remission.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dendritic cell; Lupus nephritis; Macrophages; Programmed cell death

Mesh:

Year:  2016        PMID: 27780774      PMCID: PMC5401656          DOI: 10.1016/j.clim.2016.10.007

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  206 in total

1.  The CD95 receptor: apoptosis revisited.

Authors:  Marcus E Peter; Ralph C Budd; Julie Desbarats; Stephen M Hedrick; Anne-Odile Hueber; M Karen Newell; Laurie B Owen; Richard M Pope; Juerg Tschopp; Harald Wajant; David Wallach; Robert H Wiltrout; Martin Zörnig; David H Lynch
Journal:  Cell       Date:  2007-05-04       Impact factor: 41.582

2.  RIG-I RNA helicase activation of IRF3 transcription factor is negatively regulated by caspase-8-mediated cleavage of the RIP1 protein.

Authors:  Akhil Rajput; Andrew Kovalenko; Konstantin Bogdanov; Seung-Hoon Yang; Tae-Bong Kang; Jin-Chul Kim; Jianfang Du; David Wallach
Journal:  Immunity       Date:  2011-03-25       Impact factor: 31.745

Review 3.  Treatment for lupus nephritis.

Authors:  Lorna Henderson; Philip Masson; Jonathan C Craig; Robert S Flanc; Matthew A Roberts; Giovanni F M Strippoli; Angela C Webster
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

4.  Factors associated with poor outcomes in patients with lupus nephritis.

Authors:  G Contreras; V Pardo; C Cely; E Borja; A Hurtado; C De La Cuesta; K Iqbal; O Lenz; A Asif; N Nahar; B Leclerq; C Leon; I Schulman; F Ramirez-Seijas; A Paredes; A Cepero; T Khan; F Pachon; E Tozman; G Barreto; D Hoffman; M Almeida Suarez; J C Busse; M Esquenazi; A Esquenazi; L Garcia Mayol; H Garcia Estrada
Journal:  Lupus       Date:  2005       Impact factor: 2.911

5.  Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis.

Authors:  Mary Anne Dooley; David Jayne; Ellen M Ginzler; David Isenberg; Nancy J Olsen; David Wofsy; Frank Eitner; Gerald B Appel; Gabriel Contreras; Laura Lisk; Neil Solomons
Journal:  N Engl J Med       Date:  2011-11-17       Impact factor: 91.245

6.  Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins.

Authors:  A M Verhagen; P G Ekert; M Pakusch; J Silke; L M Connolly; G E Reid; R L Moritz; R J Simpson; D L Vaux
Journal:  Cell       Date:  2000-07-07       Impact factor: 41.582

7.  Polymorphism of the FcgammaRIIalpha IgG receptor in patients with lupus nephritis and glomerulopathy.

Authors:  Adriana Peixoto Gelmetti; Antônio Carlos Freitas; Viktoria Woronik; Rui Toledo Barros; Eloísa Bonfá; Renato Costa Monteiro
Journal:  J Rheumatol       Date:  2006-03       Impact factor: 4.666

8.  Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites.

Authors:  D V Vlahakos; M H Foster; S Adams; M Katz; A A Ucci; K J Barrett; S K Datta; M P Madaio
Journal:  Kidney Int       Date:  1992-06       Impact factor: 10.612

9.  RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL.

Authors:  Kate E Lawlor; Nufail Khan; Alison Mildenhall; Motti Gerlic; Ben A Croker; Akshay A D'Cruz; Cathrine Hall; Sukhdeep Kaur Spall; Holly Anderton; Seth L Masters; Maryam Rashidi; Ian P Wicks; Warren S Alexander; Yasuhiro Mitsuuchi; Christopher A Benetatos; Stephen M Condon; W Wei-Lynn Wong; John Silke; David L Vaux; James E Vince
Journal:  Nat Commun       Date:  2015-02-18       Impact factor: 14.919

10.  Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase.

Authors:  Philip L Cohen; Roberto Caricchio; Valsamma Abraham; Todd D Camenisch; J Charles Jennette; Robert A S Roubey; H Shelton Earp; Glenn Matsushima; Elizabeth A Reap
Journal:  J Exp Med       Date:  2002-07-01       Impact factor: 14.307

View more
  2 in total

Review 1.  Programmed Cell Death Pathways in the Pathogenesis of Systemic Lupus Erythematosus.

Authors:  Fangyuan Yang; Yi He; Zeqing Zhai; Erwei Sun
Journal:  J Immunol Res       Date:  2019-12-01       Impact factor: 4.818

2.  Disulfiram alleviates pristane-induced lupus via inhibiting GSDMD-mediated pyroptosis.

Authors:  Lili Zhuang; Xiaoqing Luo; Shufan Wu; Zhangmei Lin; Yanan Zhang; Zeqing Zhai; Fangyuan Yang; Yehao Li; Jian Zhuang; Guihu Luo; Wenchao Xu; Yi He; Erwei Sun
Journal:  Cell Death Discov       Date:  2022-09-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.